Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00215670
Recruitment Status : Completed
First Posted : September 22, 2005
Last Update Posted : May 3, 2006
Sponsor:
Collaborator:
Pfizer
Information provided by:
Eyetech Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Primary Completion Date : No date given
Study Completion Date : May 2006